Systematic review with meta-analysis: Effect of fibre supplementation on chronic idiopathic constipation in adults

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 2, 2016, Pages 103-116

  Christodoulides, S ^a,b   Dimidi, E ^a,b   Fragkos, K C ^c   Farmer, A D ^a,d   Whelan, K ^b   Scott, S M ^a,e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^e Wingate Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT; LAXATIVE;

ARTICLE; CHRONIC IDIOPATHIC CONSTIPATION; CONSTIPATION; DIET SUPPLEMENTATION; DIETARY FIBER; FECES; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE; ADULT; THERAPEUTIC USE;

ADULT; CONSTIPATION; DIETARY FIBER; FLATULENCE; HUMANS; LAXATIVES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84971223718     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13662     Document Type: Article

References (65)

1. Suares NC, Ford AC,. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011; 106: 1582-91.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC,. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
3. McCrea GL, Miaskowski C, Stotts NA, Macera L, Paul SM, Varma MG,. Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation. Gend Med 2009; 6: 259-71.
4. Belsey J, Greenfield S, Candy D, Geraint M,. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 2010; 31: 938-49.
5. Guerin A, Mody R, Fok B, et al,. Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther 2014; 40: 83-92.
6. Choung RS, Branda ME, Chitkara D, et al,. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther 2011; 33: 251-60.
7. Wald A, Scarpignato C, Mueller-Lissner S, et al,. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther 2008; 28: 917-30.
8. Müller-Lissner S, Tack J, Feng Y, Schenck F, Specht Gryp R,. Levels of satisfaction with current chronic constipation treatment options in Europe-an internet survey. Aliment Pharmacol Ther 2013; 37: 137-45.
9. National Institute for Health and Care Excellence. Constipation in children and young people. NICE Qual Stand 2014; 62: 1-38.
10. Bharucha AE, Pemberton JH, Locke GR 3rd,. American Gastroenterological Association technical review on constipation. Gastroenterology 2013; 144: 218-38.
11. Ford AC, Moayyedi P, Lacy BE, et al,. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 2014; 109: S2-26.
12. Tack J, Muller-Lissner S, Stanghellini V, et al,. Diagnosis and treatment of chronic constipation - A European perspective. Neurogastroenterol Motil 2011; 23: 697-710.
13. World Gastroenterology Organization. Practice guidelines. Constipation 2007; 1: 1-10.
14. Brownlee IA,. The physiological roles of dietary fibre. Food Hydrocolloids 2011; 25: 238-50.
15. McRorie J, Pepple S, Rudolph C,. Effects of fiber laxatives and calcium docusate on regional water content and viscosity of digesta in the large intestine of the pig. Dig Dis Sci 1998; 43: 738-45.
16. Blackwood AD, Salter J, Dettmar PW, Chaplin MF,. Dietary fibre, physicochemical properties and their relationship to health. J R Soc Promot Health 2000; 120: 242-7.
17. Stephen AM, Cummings JH,. Mechanism of action of dietary fibre in the human colon. Nature 1980; 284: 283-4.
18. Eswaran S, Muir J, Chey WD,. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 718-27.
19. Johanson JF, Kralstein J,. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther 2007; 25: 599-608.
20. Commission of European Communities. Commission Directive 2008/100/EC amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions. Off J Eur Union 2008; 285: 9-13.
21. Gibson GR, Scott KP, Rastall RA, et al,. Dietary prebiotics: current status and new definition. Food Sci Technol Bull 2010; 7: 1-19.
22. Suares NC, Ford AC,. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011; 33: 895-901.
23. Higgins JPT, Green S,. Cochrane Handbook for systematic reviews of interventions. The Cochrane Collaboration 2011; version 5.1.0. Available at: www.cochrane-handbook.org (accessed 15 September 2015).
24. Liberati A, Altman DG, Tetzlaff J, et al,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: 1-27.
25. Moher D, Tricco AC,. Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr 2008; 88: 1191-9.
26. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ,. What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336: 995-8.
27. Balshem H, Helfand M, Schunemann HJ, et al,. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-6.
28. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
29. Cohen J,. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
30. Guyatt GH, Oxman AD, Kunz R, et al,. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011; 64: 1283-93.
31. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
33. Altman DG, Bland JM,. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219-9.
34. Sun X, Briel M, Walter SD, Guyatt GH,. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010; 340: 850-4.
35. Egger M, Davey-Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
36. Sterne JA, Sutton AJ, Ioannidis JP, et al,. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials. BMJ 2011; 342: 1-8.
37. Sands ML, Murphy JR,. Use of kappa statistic in determining validity of quality filtering for meta-analysis: a case study of the health effects of electromagnetic radiation. J Clin Epidemiol 1996; 49: 1045-51.
38. Fenn GC, Wilkinson PD, Lee CE, Akbar FA,. A general practice study of the efficacy of Regulan in functional constipation. Br J Clin Pract 1986; 40: 192-7.
39. Ashraf W, Park F, Lof J, Quigley EMM,. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther 1995; 9: 639-47.
40. Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B,. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr 2011; 62: 164-70.
41. Waitzberg DL, Pereira CCA, Logullo L, et al,. Microbiota benefits after inulin and partially hydrolyzed guar gum supplementation - A randomized clinical trial in constipated women. Nutr Hosp 2012; 27: 123-9.
42. López Román J, Martínez Gonzálvez AB, Luque A, et al,. The effect of a fibre enriched dietary milk product in chronic primary idiopathic constipation. Nutr Hosp 2008; 23: 12-9.
43. Surakka A, Kajander K, Rajilic M, et al,. Yoghurt containing galactooligosaccharides facilitates defecation among elderly subjects and selectively increases the number of bifidobacteria. Int J Probiotics Prebiotics 2009; 4: 65-74.
44. Badiali D, Corazziari E, Habib FI, et al,. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995; 40: 349-56.
45. Irvine EJ, Whitehead WE, Chey WD, et al,. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006; 130: 1538-51.
46. Ford AC, Suares NC,. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut 2011; 60: 209-18.
47. Harbord RM, Egger M, Sterne JA,. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006; 25: 3443-57.
48. Marlett JA, Fischer MH,. The active fraction of psyllium seed husk. Proc Nutr Soc 2003; 62: 207-9.
49. Wenzl HH, Fine KD, Schiller LR, Fordtran JS,. Determinants of decreased fecal consistency in patients with diarrhoea. Gastroenterology 1995; 108: 1729-38.
50. Wood L, Egger M, Gluud LL, et al,. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336: 601-5.
51. Khalif IL, Quigley EMM, Konovitch EA, Maximova ID,. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis 2005; 37: 838-49.
52. Falony G, Lazidou K, Verschaeren A, Weck S, Maes D, De Vuyst L,. In vitro kinetic analysis of fermentation of prebiotic inulin-type fructans by bifidobacterium species reveals four different phenotypes. Appl Environ Microbiol 2009; 75: 454-61.
53. 13C-labeling technique. J Nutr 2012; 142: 1205-12.
54. Higgins JPT, Altman DG, Gotzsche PC, et al,. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ 2011; 343: 1-9.
55. Juni P, Altman DG, Egger M,. Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-6.
56. Tomlin J, Read NW,. Laxative properties of indigestible plastic particles. BMJ 1988; 297: 1175-6.
57. McIntyre A, Vincent RM, Perkins AC, Spiller RC,. Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors. Gut 1997; 40: 223-7.
58. Yang J, Wang H, Zhou L, Xu C,. Effect of dietary fiber on constipation: a meta analysis. World J Gastroenterol 2012; 18: 7378-83.
59. Odes HS, Madar Z,. A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation. Digestion 1991; 49: 65-71.
60. Hongisto S, Paajanen L, Saxelin M, Korpela R,. A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr 2006; 60: 319-24.
61. Rao SSC, Yu S, Fedewa A,. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015; 41: 1256-70.
62. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SSC,. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther 2011; 33: 822-8.
63. Schmier JK, Miller PE, Levine JA, et al,. Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model. BMC Public Health 2014; 14: 1-7.
64. Citronberg J, Kantor ED, Potter JD, White E,. A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk. Am J Gastroenterol 2014; 109: 1640-9.
65. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM,. Chronic constipation: overview and challenges. Neurogastroenterol Motil 2009; 21 (Suppl. 2): 1-8.